CWM
ABBV icon

Cherrydale Wealth Management’s AbbVie ABBV Stock Holding History

Cherrydale Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Sell
1,557
-63
-4% -$13.6K 0.1% 57
2026
Q1 		$352K Buy
1,620
+13
+0.8% +$2.88K 0.11% 52
2025
Q4 		$367K Hold
1,607
– – 0.11% 51
2025
Q3 		$372K Hold
1,607
– – 0.12% 53
2025
Q2 		$298K Buy
1,607
+22
+1% +$4.09K 0.1% 54
2025
Q1 		$332K Hold
1,585
– – 0.13% 50
2024
Q4 		$282K Buy
1,585
+24
+2% +$4.41K 0.11% 53
2024
Q3 		$308K Buy
+1,561
New +$291K 0.13% 49
2024
Q2 		– Sell
-1,436
Closed -$261K – 68
2024
Q1 		$261K Buy
+1,436
New +$247K 0.12% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cherrydale Wealth Management's ABBV Position: Q2 2026 in Review

Cherrydale Wealth Management reduced its AbbVie (ABBV) stake by 3.9% in Q2 2026, selling an estimated $13.6K and leaving 1,557 shares worth $392K. The position accounts for 0.1% of the portfolio, ranked #57.

Cherrydale Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cherrydale Wealth Management held 1,557 shares of AbbVie worth $392K as of Q2 2026.
  • Cherrydale Wealth Management sold 63 AbbVie shares in Q2 2026, an estimated $13.6K.
  • AbbVie made up 0.1% of Cherrydale Wealth Management's portfolio in Q2 2026, its #57 holding.
  • Cherrydale Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cherrydale Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.